Epidermal growth factor receptor (EGFR); Janus kinase-2 (JAK-2); PTEN (MMAC1; TEP1) BriefCommunication Pages: 917 - 917
Src; epidermal growth factor receptor 1 (EGFR1; HER1; ErbB1); HER2 (EGFR2; ErbB2; neu) BriefCommunication Pages: 918 - 918
c-Myc (MYC); mammalian target of rapamycin (mTOR; FRAP; RAFT1); 3-phosphoinositide dependent protein kinase-1 (PDPK1); polo-like kinase 1 (PLK1; STPK13) BriefCommunication Pages: 919 - 919
Epidermal growth factor receptor (EGFR); heat shock protein 90 (Hsp90) BriefCommunication Pages: 920 - 920
Prostate cancer non-coding RNA 1 (PRNCR1); prostate-specific transcript 1 (PCGEM1) BriefCommunication Pages: 926 - 926
Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2); hypoxia-inducible factor 1α (HIF1A; HIF1α) BriefCommunication Pages: 927 - 927
β-Amyloid (Aβ); β-site APP-cleaving enzyme 1 (BACE1); mammalian target of rapamycin (mTOR; FRAP; RAFT1) BriefCommunication Pages: 930 - 930
Mouse model of sympathetic nervous system activation in metabolic syndrome BriefCommunication Pages: 940 - 940
2′-O-methyltransferase–deficient, live, attenuated dengue virus vaccine BriefCommunication Pages: 942 - 942
Small molecules that prevent teratoma formation in human pluripotent stem cell–derived therapies BriefCommunication Pages: 943 - 943
Transcription activator-like effector nucleases (TALENs) to eliminate mitochondria-specific mutant DNA BriefCommunication Pages: 944 - 944
Noninvasive, 3D imaging of retinal and choroidal vasculature using phase-variance optical coherence tomography BriefCommunication Pages: 945 - 945
Ribosomal protein S6 kinase (RSK) phosphorylation to predict response to BRAF, MEK or phosphoinositide 3-kinase (PI3K) inhibitors BriefCommunication Pages: 946 - 946